Trial Profile
A Phase II Prospective, Randomized, Double-Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Ophthalmic Suspension Compared to Placebo for the Treatment of Dry Eye Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Sep 2014
Price :
$35
*
At a glance
- Drugs Rivoglitazone (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Santen Pharmaceutical
- 03 Sep 2014 New trial record